Cover storyA sprained ankle, an arthritis flare, a patient who can't swallow pills, here's when doctors reach for meloxicam injection instead.
Chugai Pharmaceutical partners with the Japan Basketball Association to promote innovation, public health, and basketball development in Japan.
Nurix Therapeutics enrolls the first patient in its Phase 3 DAYBreak CLL-306 trial evaluating bexobrutideg for relapsed or refractory CLL/SLL.
Sanofi wins EU approval to expand MenQuadfi vaccine use to infants from six weeks of age, broadening protection against meningococcal disease.
Teladoc Health appoints former Verisk executive Mark Anquillare to its Board to support growth, technology, and AI strategy initiatives.
AEON Biopharma regains NYSE American listing compliance after a $13.6 million public offering strengthens its shareholders' equity position.
Interview20260622153015.png&w=1920&q=75&dpl=dpl_GGkXARwZ1w2xRMDJpZjTP7g1TvsA)
Interview
Interview
Podcast
Aug 12
Sep 28
Nov 18From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.
Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
20260804110923.webp&w=1920&q=75&dpl=dpl_GGkXARwZ1w2xRMDJpZjTP7g1TvsA)
